Placing a study at the wrong site can cost you months: slow recruitment, a failed inspection, rejected data or a participant-safety issue. SER independently assesses clinical trial sites, BA/BE centres and bioanalytical laboratories in India before you commit, so you choose sites on evidence rather than on the site’s own sales pitch.
Clinical Trial Sites
Hospitals and investigator sites for Phase I–IV trials
BA/BE Centres
Clinical units running bioavailability and bioequivalence studies
Bioanalytical Labs
Laboratories analysing PK samples for BA/BE and clinical studies
Who It’s For
Sponsors and CROs selecting sites for clinical trials and BA/BE studies in India, whether you are based here or overseas.
Sites preparing for a sponsor’s qualification visit, who want an independent view of where they stand first.
What You Get
- A pre-qualification report with a risk rating for each area
- A list of critical and major observations
- A clear go / conditional go / no-go recommendation
- An optional follow-up visit to verify corrective actions (CAPA)
What We Assess
Regulatory Standing
CDSCO approvals, ethics committee arrangements and past inspection outcomes (CDSCO, USFDA, EMA, WHO).
Investigator and Team
Qualifications, GCP training, workload and experience in the therapeutic area.
Recruitment and Consent
Patient or volunteer pool, screening, duplicate-participation checks and the informed consent process.
Facilities
Clinical areas, emergency and ICU arrangements, pharmacy, and investigational product storage and accountability.
Samples and Data
Collection, processing, storage and chain of custody; for BA/BE, method validation, instrument qualification and data integrity (ALCOA+).
Quality System
SOPs, deviation and CAPA handling, training records and computerised system validation.
Why SER
Our founder has spent more than three decades in clinical research quality and operations, including setting up and running BA/BE units of 200 and 117 beds with CAP-accredited labs, and has led global QA through regulatory inspections. We know what a strong site looks like from the inside, and we assess yours the way an inspector will.
Frequently Asked Questions
Do you qualify sites for patient trials as well as BA/BE studies?
Yes. We assess sites for Phase I–IV clinical trials as well as BA/BE centres and the bioanalytical labs that support them.
How long does a pre-qualification audit take?
It depends on the size of the site and the scope you need. We agree the duration of the visit and the report timeline with you before we start.
Can you audit sites outside Delhi NCR?
Yes. We can assess sites elsewhere in India, with travel agreed as part of the scope.
Do you work with overseas sponsors?
Yes. We schedule calls and reporting around your time zone, and all our reports are written in English.
Can audits run remotely?
Document and SOP reviews can be done remotely. Facility, sample-handling and process checks are done on site.
Choosing sites for your next study?
Tell us about the study and the sites you’re considering, and we’ll propose the scope of the assessment.

